Mus vs Zimbabwe: Previously treated cases tested for RR-/MDR-TB (%)
Mus
100.0%
in 2022
Zimbabwe
100.0%
in 2024
Mus rank
1st
Zimbabwe rank
1st
Previously treated cases tested for RR-/MDR-TB (%) over time
- Mus
- Zimbabwe
How they compare
Mus currently reports 100.0% against 100.0% in Zimbabwe, a difference of 0.0%.
The two have swapped places 3 times across 7 shared years of data; in 2011 it was Mus ahead.
Mus ranks 1st and Zimbabwe ranks 1st of 2 regions.
Mus has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Mus | Zimbabwe | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 92.0% | 34.7% | 57.3% | Mus |
| 2020s | 100.0% | 96.0% | 4.0% | Mus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Mus or Zimbabwe?
- Mus, at 100.0% against 100.0% in Zimbabwe as of 2022.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Mus and Zimbabwe?
- 0.0%, with Mus ahead.
- How many years of comparable data are there for Mus and Zimbabwe?
- 7 years are reported by both, from 2011 to 2022.
- How do Mus and Zimbabwe rank globally for previously treated cases tested for rr-/mdr-tb?
- Mus ranks 1st and Zimbabwe ranks 1st of 2 regions.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.